JAK-话题@MedSci

#JAK#

115篇内容 | 1206人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1737976, encodeId=58221e379769d, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=【盘点】JAK-STAT 信号通路靶向药物浅析, objectType=article, longId=113336, objectId=044d113336af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=044d113336af, replyNumber=0, likeNumber=53, createdTime=2017-12-10, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=044d113336af, moduleTitle=【盘点】JAK-STAT 信号通路靶向药物浅析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=044d113336af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737980, encodeId=bf411e37980a6, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Sci Rep：研究发现治疗类风湿性关节炎的高选择性JAK3抑制剂, objectType=article, longId=133774, objectId=6f84133e747e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f84133e747e, replyNumber=0, likeNumber=30, createdTime=2018-08-26, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f84133e747e, moduleTitle=Sci Rep：研究发现治疗类风湿性关节炎的高选择性JAK3抑制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f84133e747e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737978, encodeId=a4091e3797807, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Leukemia：重磅！有望通过调控JAK/STAT信号通路减少T-ALL患者糖皮质激素抵抗！, objectType=article, longId=125039, objectId=495112503910, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=495112503910, replyNumber=0, likeNumber=32, createdTime=2018-05-29, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=495112503910, moduleTitle=Leukemia：重磅！有望通过调控JAK/STAT信号通路减少T-ALL患者糖皮质激素抵抗！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=495112503910)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737975, encodeId=f2271e3797515, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Blood：JAK1/2抑制剂与BCL2抑制剂联用或能打破骨髓微环境的保护作用, objectType=article, longId=102563, objectId=be2010256397, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be2010256397, replyNumber=0, likeNumber=33, createdTime=2017-08-22, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be2010256397, moduleTitle=Blood：JAK1/2抑制剂与BCL2抑制剂联用或能打破骨髓微环境的保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be2010256397)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737972, encodeId=4d041e379722c, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=欧盟受理辉瑞口服JAK抑制剂Xeljanz治疗类风湿性关节炎的上市申请, objectType=article, longId=65589, objectId=dd6c6558973, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd6c6558973, replyNumber=0, likeNumber=43, createdTime=2016-04-03, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd6c6558973, moduleTitle=欧盟受理辉瑞口服JAK抑制剂Xeljanz治疗类风湿性关节炎的上市申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd6c6558973)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737974, encodeId=8f651e3797438, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=FDA授予Jakavi（鲁索替尼）治疗急性移植物抗宿主病（GVHD）的突破性药物资格, objectType=article, longId=71612, objectId=40d3e1612a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40d3e1612a3, replyNumber=0, likeNumber=42, createdTime=2017-01-14, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40d3e1612a3, moduleTitle=FDA授予Jakavi（鲁索替尼）治疗急性移植物抗宿主病（GVHD）的突破性药物资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40d3e1612a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737973, encodeId=241f1e379738c, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=诺华抗癌药Jakavi达真性红细胞增多症III期临床主要终点, objectType=article, longId=71290, objectId=e56ee129027, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e56ee129027, replyNumber=0, likeNumber=40, createdTime=2016-08-29, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e56ee129027, moduleTitle=诺华抗癌药Jakavi达真性红细胞增多症III期临床主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e56ee129027)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737970, encodeId=1b881e37970b3, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Science advance：斑秃不再可怕——JAK抑制剂或可还你一头茂密的头发, objectType=article, longId=57783, objectId=38555e783a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38555e783a7, replyNumber=0, likeNumber=25, createdTime=2015-12-20, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38555e783a7, moduleTitle=Science advance：斑秃不再可怕——JAK抑制剂或可还你一头茂密的头发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38555e783a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737971, encodeId=c56b1e37971b5, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=FDA批准辉瑞全球每日一次的口服JAK抑制剂类风湿药Xeljanz XR, objectType=article, longId=63870, objectId=c052638e07b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c052638e07b, replyNumber=0, likeNumber=21, createdTime=2016-03-05, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c052638e07b, moduleTitle=FDA批准辉瑞全球每日一次的口服JAK抑制剂类风湿药Xeljanz XR, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c052638e07b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737969, encodeId=46de1e37969a1, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Clin Cancer Res.：JAK抑制剂可能潜在预防急性移植物抗宿主病, objectType=article, longId=50870, objectId=1ab4508e0f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ab4508e0f6, replyNumber=0, likeNumber=26, createdTime=2015-09-11, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ab4508e0f6, moduleTitle=Clin Cancer Res.：JAK抑制剂可能潜在预防急性移植物抗宿主病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ab4508e0f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737968, encodeId=9e141e379684f, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=诺华重磅药物Jakavi欧盟收获新适应症：真性红细胞增多症（PV）, objectType=article, longId=48434, objectId=d5af48434cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5af48434cb, replyNumber=0, likeNumber=39, createdTime=2015-10-07, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5af48434cb, moduleTitle=诺华重磅药物Jakavi欧盟收获新适应症：真性红细胞增多症（PV）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5af48434cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737966, encodeId=0c0c1e37966af, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Hepatology：肝癌中GADD45G下调促进了Jak-Stat3信号通路激活, objectType=article, longId=26935, objectId=fd4026935b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd4026935b0, replyNumber=0, likeNumber=23, createdTime=2014-08-25, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd4026935b0, moduleTitle=Hepatology：肝癌中GADD45G下调促进了Jak-Stat3信号通路激活, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd4026935b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737967, encodeId=94031e379675b, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=诺华Jakavi III期试验达主要终点, objectType=article, longId=31686, objectId=87cd3168624, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87cd3168624, replyNumber=0, likeNumber=36, createdTime=2014-09-04, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87cd3168624, moduleTitle=诺华Jakavi III期试验达主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87cd3168624)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737965, encodeId=8f831e379653c, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Cancer Dis：JAK3基因突变为淋巴瘤潜在治疗靶标, objectType=article, longId=7224, objectId=d7d3e2249e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7d3e2249e, replyNumber=0, likeNumber=34, createdTime=2013-05-15, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7d3e2249e, moduleTitle=Cancer Dis：JAK3基因突变为淋巴瘤潜在治疗靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7d3e2249e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737964, encodeId=14021e3796468, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=欧洲药管局或将批准血液药物Jakavi, objectType=article, longId=5798, objectId=2fd25e9809, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fd25e9809, replyNumber=0, likeNumber=31, createdTime=2012-11-10, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fd25e9809, moduleTitle=欧洲药管局或将批准血液药物Jakavi, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fd25e9809)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

JAK

2020-05-29

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

【盘点】JAK-STAT 信号通路靶向药物浅析

2017-12-10

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Sci Rep：研究发现治疗类风湿性关节炎的高选择性JAK3抑制剂

2018-08-26

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Leukemia：重磅！有望通过调控JAK/STAT信号通路减少T-ALL患者糖皮质激素抵抗！

2018-05-29

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Blood：JAK1/2抑制剂与BCL2抑制剂联用或能打破骨髓微环境的保护作用

2017-08-22

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

欧盟受理辉瑞口服JAK抑制剂Xeljanz治疗类风湿性关节炎的上市申请

2016-04-03

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

FDA授予Jakavi（鲁索替尼）治疗急性移植物抗宿主病（GVHD）的突破性药物资格

2017-01-14

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

诺华抗癌药Jakavi达真性红细胞增多症III期临床主要终点

2016-08-29

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Science advance：斑秃不再可怕——JAK抑制剂或可还你一头茂密的头发

2015-12-20

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

FDA批准辉瑞全球每日一次的口服JAK抑制剂类风湿药Xeljanz XR

2016-03-05

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Clin Cancer Res.：JAK抑制剂可能潜在预防急性移植物抗宿主病

2015-09-11

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

诺华重磅药物Jakavi欧盟收获新适应症：真性红细胞增多症（PV）

2015-10-07

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Hepatology：肝癌中GADD45G下调促进了Jak-Stat3信号通路激活

2014-08-25

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

诺华Jakavi III期试验达主要终点

2014-09-04

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Cancer Dis：JAK3基因突变为淋巴瘤潜在治疗靶标

2013-05-15

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

欧洲药管局或将批准血液药物Jakavi

2012-11-10

科室
- - 订阅+
  - 更多科室
工具
服务